What Animal Models are Useful in Selecting New Antiarrhythmic Drugs?

  • E. Neil Moore
  • Joseph F. Spear
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 47)


Although many animal models are useful for evaluating new antiarrhythmic agents, it must be admitted that no animal model is ideal, nor can any single animal model alone predict antiarrhythmic efficacy in man. The selection of which animal model(s) to use depends first of all on whether one is “screening” for a new active compound or alternatively, “evaluating” an already identified active antiarrhythmic drug. This paper will deal primarily with models designed to evaluate mechanisms of action and effectiveness of new antiarrhythmic agents.


Left Anterior Descend Ventricular Fibrillation Antiarrhythmic Drug Antiarrhythmic Agent Ventricular Tachyarrhythmia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Moore EN and Spear JF: Acute animal models for the study of antiarrhythmic drugs for the prevention of sudden coronary death. In: Clinical Pharmacology of Antiarrhythmic Therapy. Ed. Lucchesi, BR, Dingell, JV and Schwarz RP Jr. Raven Press, N.Y. pp. 31–46, 1984.Google Scholar
  2. Wiggers, CJ, and Wegria R: Ventricular fibrillation due to a single localized induction and condenser shock applied during the vulnerable phase of ventricular systole. Am. J. Physiol. 128: 500–505.Google Scholar
  3. 3.
    Euler DE and Moore EN: Continuous fractionated electrical activity after stimulation of the ventricles during the vulnerable period: evidence for local reentry. Am. J. Cardiol. 46: 783–791, 1980.PubMedCrossRefGoogle Scholar
  4. 4.
    Han J: Ventricular vulnerability during acute coronary occlusion. Am. J Cardiol. 24: 857–864, 1969.PubMedCrossRefGoogle Scholar
  5. 5.
    Greenberg, HM and Dwyer, EM. Eds. Sudden Coronary Death Ann. NY Acad. Sci. 382: 1–484, 1982.Google Scholar
  6. 6.
    Kaplinsky, E, Ogawa S, Balke CW and Dreifus LS: Two periods of early ventricular arrhythmia in the canine acute myocardial infarction model. Circ. 60: 397–403, 1979.Google Scholar
  7. 7.
    Harris, AS and Rojas, AG: Initiation of ventricular fibrillation due to coronary occlusion. Exp. Med. Surg. 1: 105–122, 1943.Google Scholar
  8. 8.
    Moore, EN, Spear, JF, Feldman HS and Moller R: Electrophysiological properties of a new antiarrhythmic drug — Tocainide. Am. J. Cardiol. 41: 703–708, 1978.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1985

Authors and Affiliations

  • E. Neil Moore
  • Joseph F. Spear

There are no affiliations available

Personalised recommendations